Good morning, everyone, and how are you today? Another spot of rain is hovering over the Pharmalot corporate campus, where we are hustling the short people off to school and planning another busy day of phone calls and R&D. We trust you can relate. But, as they say, busy is good. Speaking of which, please join us tomorrow for a webinar on salesforce effectiveness (
see this). Meanwhile, here are some tidbits to get you started. Catch you later...FDA Rejects Pfizer Drug For Rare Neurodegenerative Disease (Reuters)
Fake Drugs Threaten Gains In Fighting Malaria (Reuters)
J&J's Simponi Helps Colitis Patients In Trial (Dow Jones)
Combo Treatment For IPF Raises Risk Of Death (MedPage Today)
Servier Trial In France Delayed Over Appeal (Reuters)
Bayer's Nexavar Fails In Lung Cancer Study (Pharma Times)
Chinese Doctor Questions Off-Label Use Of Xarelto (East Day)
Takeda To Close California R&D Site (San Francisco Business Times)
Astellas And Medivation File Prostate Cancer Drug In US (Pharma Times)
Pakistan Warned Of Shortages Over Pricing Policy (The Tribune)
EDITOR'S NOTE: Please check this post for updates
steaming coffee pix thx to dleggett on flickr
3 Comments
Certainly not MEEE!!!! I feel like such a STUPID, NAIVE, GULLIBLE...fool!!!!!!!!! I trusted BLINDLY, complete strangers w/my LIFE!! Never again. Never again will I put my faith and trust in any of the above. I'm done. Greed is ugly...and CAN be DEADLY. Save yourself!! Do your homework before ingesting any new drug and always get a second opinion on any diagnosis you receive. No one's REALLY got your back. KNOW that. You are your own best advocate!!!!!!!!!!!!